Neratovice, Czechia

Marcel Patek

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcel Patek. Retrieved from https://idiyas.com/inventor/marcel-patek-q6ioglmz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marcel Patek: Innovator in Pharmaceutical Chemistry

Introduction

Marcel Patek is a notable inventor based in Neratovice, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on urea derivatives.

Latest Patents

Marcel Patek holds a patent for "Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use." This invention relates to new products of formula (I) and showcases his expertise in developing pharmaceutical solutions.

Career Highlights

Patek is currently associated with Amgen Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Amgen has allowed him to contribute to advancements in healthcare and medicine.

Collaborations

One of his notable collaborators is Pierre Deprez, with whom he has worked on various projects in the pharmaceutical domain.

Conclusion

Marcel Patek's contributions to pharmaceutical chemistry through his patent and work at Amgen Inc. highlight his role as an innovator in the field. His dedication to developing new medicinal products continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…